2-hydroxyphenylacetic acid has been researched along with Multiple Myeloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belmontes, B; Brown, SP; Caenepeel, S; Cardozo, M; Cheng, AC; Chow, D; Dou, H; Gonzalez, AZ; Houze, J; Huang, X; Hughes, PE; Jabri, S; Jones, A; Kelly, RC; Li, Y; Lizarzaburu, M; Lo, MC; Mallari, R; Medina, JC; Meleza, C; Moody, G; Rescourio, G; Rew, Y; Simonovich, S; Sun, D; Turcotte, S; Whittington, D; Wong, SG; Yan, X; Yanez, E; Zancanella, M | 1 |
1 other study(ies) available for 2-hydroxyphenylacetic acid and Multiple Myeloma
| Article | Year |
|---|---|
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Drug Stability; Female; Humans; Hydrogen Bonding; Mice, Nude; Multiple Myeloma; Myeloid Cell Leukemia Sequence 1 Protein; Phenylacetates; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides; Xenograft Model Antitumor Assays | 2019 |